<?xml-stylesheet type="text/xsl" href="varreports_v3.xsl"?><data_table name="C1HEMO" dataset_id="pht001694.v2" study_name="CARDIA Cohort" study_id="phs000285.v3" participant_set="2" date_created="08/20/2013"><variable id="phv00116360.v2.p2" var_name="Individual_ID" calculated_type="string" reported_type="string"><description>Subject Identifier</description><total><subject_profile><sex><male>451</male><female>486</female></sex></subject_profile><stats><stat n="1487" nulls="0"/></stats></total></variable><variable id="phv00116360.v2.p2.c1" var_name="Individual_ID" calculated_type="string" reported_type="string"><description>Subject Identifier</description><total><subject_profile><sex><male>428</male><female>471</female></sex></subject_profile><stats><stat n="1428" nulls="0"/></stats></total></variable><variable id="phv00116360.v2.p2.c2" var_name="Individual_ID" calculated_type="string" reported_type="string"><description>Subject Identifier</description><total><subject_profile><sex><male>23</male><female>15</female></sex></subject_profile><stats><stat n="59" nulls="0"/></stats></total></variable><variable id="phv00116361.v2.p2" var_name="CLEFACT7" calculated_type="decimal" units="%" reported_type="decimal"><description>FACTOR VII (%)</description><total><subject_profile><sex><male>451</male><female>485</female></sex></subject_profile><stats><stat n="1486" nulls="1" mean="84.05" sd="23.36" median="81" min="29" max="441"/><example count="43">73.0</example><example count="41">77.0</example><example count="36">90.0</example><example count="34">80.0</example><example count="33">82.0</example><example count="32">85.0</example><example count="31">79.0</example><example count="31">71.0</example><example count="30">75.0</example><example count="30">67.0</example></stats></total></variable><variable id="phv00116361.v2.p2.c1" var_name="CLEFACT7" calculated_type="decimal" units="%" reported_type="decimal"><description>FACTOR VII (%)</description><total><subject_profile><sex><male>428</male><female>470</female></sex></subject_profile><stats><stat n="1427" nulls="1" mean="84.24" sd="23.49" median="82" min="29" max="441"/><example count="40">77.0</example><example count="40">73.0</example><example count="35">90.0</example><example count="32">80.0</example><example count="31">71.0</example><example count="31">82.0</example><example count="31">85.0</example><example count="30">67.0</example><example count="30">87.0</example><example count="29">79.0</example></stats></total></variable><variable id="phv00116361.v2.p2.c2" var_name="CLEFACT7" calculated_type="decimal" units="%" reported_type="decimal"><description>FACTOR VII (%)</description><total><subject_profile><sex><male>23</male><female>15</female></sex></subject_profile><stats><stat n="59" nulls="0" mean="79.58" sd="19.68" median="79" min="40" max="127"/><example count="3">60.0</example><example count="3">73.0</example><example count="3">56.0</example><example count="2">91.0</example><example count="2">79.0</example><example count="2">80.0</example><example count="2">82.0</example><example count="2">81.0</example><example count="2">55.0</example><example count="2">63.0</example></stats></total></variable><variable id="phv00116362.v2.p2" var_name="CLEFACT8" calculated_type="decimal" units="%" reported_type="decimal"><description>FACTOR VIII (%)</description><total><subject_profile><sex><male>451</male><female>486</female></sex></subject_profile><stats><stat n="1487" nulls="0" mean="95.27" sd="35.48" median="91" min="14" max="246"/><example count="26">92.0</example><example count="25">89.0</example><example count="24">95.0</example><example count="24">65.0</example><example count="22">80.0</example><example count="22">96.0</example><example count="21">83.0</example><example count="21">100.0</example><example count="20">102.0</example><example count="20">78.0</example></stats></total></variable><variable id="phv00116362.v2.p2.c1" var_name="CLEFACT8" calculated_type="decimal" units="%" reported_type="decimal"><description>FACTOR VIII (%)</description><total><subject_profile><sex><male>428</male><female>471</female></sex></subject_profile><stats><stat n="1428" nulls="0" mean="95.56" sd="35.37" median="91.5" min="14" max="246"/><example count="25">92.0</example><example count="23">89.0</example><example count="23">95.0</example><example count="22">96.0</example><example count="22">65.0</example><example count="21">80.0</example><example count="21">83.0</example><example count="21">100.0</example><example count="20">102.0</example><example count="20">88.0</example></stats></total></variable><variable id="phv00116362.v2.p2.c2" var_name="CLEFACT8" calculated_type="decimal" units="%" reported_type="decimal"><description>FACTOR VIII (%)</description><total><subject_profile><sex><male>23</male><female>15</female></sex></subject_profile><stats><stat n="59" nulls="0" mean="88.37" sd="37.8" median="81" min="31" max="210"/><example count="3">69.0</example><example count="2">89.0</example><example count="2">81.0</example><example count="2">127.0</example><example count="2">84.0</example><example count="2">67.0</example><example count="2">73.0</example><example count="2">64.0</example><example count="2">52.0</example><example count="2">65.0</example></stats></total></variable><variable id="phv00116363.v2.p2" var_name="CLEFIBR" calculated_type="decimal" units="MG/DL" reported_type="integer"><description>FIBRINOGEN (MG/DL)</description><total><subject_profile><sex><male>451</male><female>486</female></sex></subject_profile><stats><stat n="1486" nulls="1" mean="263" sd="64.53" median="255.5" min="63" max="659"/><example count="32">276.0</example><example count="18">241.0</example><example count="18">250.0</example><example count="17">278.0</example><example count="16">240.0</example><example count="15">257.0</example><example count="15">228.0</example><example count="15">230.0</example><example count="15">201.0</example><example count="15">288.0</example></stats></total></variable><variable id="phv00116363.v2.p2.c1" var_name="CLEFIBR" calculated_type="decimal" units="MG/DL" reported_type="integer"><description>FIBRINOGEN (MG/DL)</description><total><subject_profile><sex><male>428</male><female>471</female></sex></subject_profile><stats><stat n="1427" nulls="1" mean="263.6" sd="64.75" median="256" min="63" max="659"/><example count="31">276.0</example><example count="18">250.0</example><example count="17">241.0</example><example count="15">230.0</example><example count="15">278.0</example><example count="15">240.0</example><example count="15">232.0</example><example count="14">257.0</example><example count="14">228.0</example><example count="14">201.0</example></stats></total></variable><variable id="phv00116363.v2.p2.c2" var_name="CLEFIBR" calculated_type="decimal" units="MG/DL" reported_type="integer"><description>FIBRINOGEN (MG/DL)</description><total><subject_profile><sex><male>23</male><female>15</female></sex></subject_profile><stats><stat n="59" nulls="0" mean="250.1" sd="57.79" median="249" min="124" max="446"/><example count="3">198.0</example><example count="2">273.0</example><example count="2">294.0</example><example count="2">219.0</example><example count="2">278.0</example><example count="2">238.0</example><example count="2">293.0</example><example count="2">267.0</example><example count="1">300.0</example><example count="1">257.0</example></stats></total></variable><variable id="phv00116364.v2.p2" var_name="CLEVWANT" calculated_type="decimal" units="%" reported_type="decimal"><description>VON WILLEBRAND ANTIGEN (%)</description><total><subject_profile><sex><male>451</male><female>486</female></sex></subject_profile><stats><stat n="1487" nulls="0" mean="105" sd="46.24" median="95" min="21" max="432"/><example count="31">90.0</example><example count="26">94.0</example><example count="25">98.0</example><example count="24">103.0</example><example count="24">96.0</example><example count="22">100.0</example><example count="21">101.0</example><example count="21">93.0</example><example count="21">92.0</example><example count="20">79.0</example></stats></total></variable><variable id="phv00116364.v2.p2.c1" var_name="CLEVWANT" calculated_type="decimal" units="%" reported_type="decimal"><description>VON WILLEBRAND ANTIGEN (%)</description><total><subject_profile><sex><male>428</male><female>471</female></sex></subject_profile><stats><stat n="1428" nulls="0" mean="105.4" sd="46.33" median="96" min="21" max="432"/><example count="30">90.0</example><example count="25">98.0</example><example count="24">94.0</example><example count="23">103.0</example><example count="21">96.0</example><example count="21">101.0</example><example count="21">93.0</example><example count="20">79.0</example><example count="20">100.0</example><example count="20">95.0</example></stats></total></variable><variable id="phv00116364.v2.p2.c2" var_name="CLEVWANT" calculated_type="decimal" units="%" reported_type="decimal"><description>VON WILLEBRAND ANTIGEN (%)</description><total><subject_profile><sex><male>23</male><female>15</female></sex></subject_profile><stats><stat n="59" nulls="0" mean="96.68" sd="43.51" median="89" min="32" max="235"/><example count="3">88.0</example><example count="3">96.0</example><example count="2">89.0</example><example count="2">77.0</example><example count="2">94.0</example><example count="2">76.0</example><example count="2">63.0</example><example count="2">58.0</example><example count="2">36.0</example><example count="2">100.0</example></stats></total></variable><variable id="phv00116365.v2.p2" var_name="CLEVWACT" calculated_type="decimal" units="%" reported_type="decimal"><description>VON WILLEBRAND ACTIVITY (%)</description><total><subject_profile><sex><male>451</male><female>486</female></sex></subject_profile><stats><stat n="1485" nulls="2" mean="91.34" sd="39.47" median="85" min="10" max="343"/><example count="25">86.0</example><example count="24">90.0</example><example count="23">77.0</example><example count="22">61.0</example><example count="21">81.0</example><example count="21">63.0</example><example count="20">69.0</example><example count="20">76.0</example><example count="20">80.0</example><example count="20">82.0</example></stats></total></variable><variable id="phv00116365.v2.p2.c1" var_name="CLEVWACT" calculated_type="decimal" units="%" reported_type="decimal"><description>VON WILLEBRAND ACTIVITY (%)</description><total><subject_profile><sex><male>428</male><female>471</female></sex></subject_profile><stats><stat n="1426" nulls="2" mean="91.57" sd="39.34" median="86" min="10" max="343"/><example count="25">86.0</example><example count="23">90.0</example><example count="22">77.0</example><example count="21">81.0</example><example count="21">61.0</example><example count="20">76.0</example><example count="20">80.0</example><example count="20">93.0</example><example count="20">92.0</example><example count="19">69.0</example></stats></total></variable><variable id="phv00116365.v2.p2.c2" var_name="CLEVWACT" calculated_type="decimal" units="%" reported_type="decimal"><description>VON WILLEBRAND ACTIVITY (%)</description><total><subject_profile><sex><male>23</male><female>15</female></sex></subject_profile><stats><stat n="59" nulls="0" mean="85.88" sd="42.43" median="77" min="20" max="256"/><example count="3">78.0</example><example count="3">54.0</example><example count="3">63.0</example><example count="3">65.0</example><example count="3">47.0</example><example count="2">104.0</example><example count="2">97.0</example><example count="2">85.0</example><example count="2">64.0</example><example count="2">100.0</example></stats></total></variable><variable id="phv00116366.v2.p2" var_name="CLEBTYPE" calculated_type="string" reported_type="string"><description>ABO BLOOD TYPE</description><total><subject_profile><sex><male>445</male><female>467</female></sex></subject_profile><stats><stat n="1440" nulls="47"/><enum count="645">O</enum><enum count="485">A</enum><enum count="246">B</enum><enum count="64">AB</enum></stats></total></variable><variable id="phv00116366.v2.p2.c1" var_name="CLEBTYPE" calculated_type="string" reported_type="string"><description>ABO BLOOD TYPE</description><total><subject_profile><sex><male>424</male><female>452</female></sex></subject_profile><stats><stat n="1384" nulls="44"/><enum count="619">O</enum><enum count="462">A</enum><enum count="243">B</enum><enum count="60">AB</enum></stats></total></variable><variable id="phv00116366.v2.p2.c2" var_name="CLEBTYPE" calculated_type="string" reported_type="string"><description>ABO BLOOD TYPE</description><total><subject_profile><sex><male>21</male><female>15</female></sex></subject_profile><stats><stat n="56" nulls="3"/><enum count="26">O</enum><enum count="23">A</enum><enum count="4">AB</enum><enum count="3">B</enum></stats></total></variable><variable id="phv00116367.v2.p2" var_name="CLELEWIS" calculated_type="string" reported_type="string"><description>LEWIS BLOOD GROUP PHENOTYPE</description><total><subject_profile><sex><male>420</male><female>444</female></sex></subject_profile><stats><stat n="1375" nulls="112"/><enum count="778">-+</enum><enum count="360">--</enum><enum count="232">+-</enum><enum count="5">++</enum></stats></total></variable><variable id="phv00116367.v2.p2.c1" var_name="CLELEWIS" calculated_type="string" reported_type="string"><description>LEWIS BLOOD GROUP PHENOTYPE</description><total><subject_profile><sex><male>399</male><female>432</female></sex></subject_profile><stats><stat n="1324" nulls="104"/><enum count="748">-+</enum><enum count="349">--</enum><enum count="223">+-</enum><enum count="4">++</enum></stats></total></variable><variable id="phv00116367.v2.p2.c2" var_name="CLELEWIS" calculated_type="string" reported_type="string"><description>LEWIS BLOOD GROUP PHENOTYPE</description><total><subject_profile><sex><male>21</male><female>12</female></sex></subject_profile><stats><stat n="51" nulls="8"/><enum count="30">-+</enum><enum count="11">--</enum><enum count="9">+-</enum><enum count="1">++</enum></stats></total></variable></data_table>
